Clemastine Treatment in Individuals With Williams Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study explores the neurobiological etiology of Williams syndrome and potential therapeutic targets for associated social, motor, and cognitive abnormalities. The main translational objective will be to test the effectiveness of Clemasntine on neurocognitive and other associated abnormalities in individuals with Williams syndrome.
Epistemonikos ID: e093bb0d6f5012a0ba67087c2e6bfd4baeb34928
First added on: May 15, 2024